Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

1.

Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.

Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.

Pediatr Pulmonol. 2000 Aug;30(2):97-105.

PMID:
10922131
2.
4.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.

J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16.

PMID:
10856143
5.

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.

Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.

Can Respir J. 1999 Jan-Feb;6(1):45-51.

PMID:
10202220
6.

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.

Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):273-80.

PMID:
10094218
7.

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.

J Allergy Clin Immunol. 1998 Jul;102(1):32-8.

PMID:
9679845
8.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
9.
11.

Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).

Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M; Viani-Initial Study Group..

Eur J Med Res. 2002 Jan 29;7(1):1-7.

PMID:
11827834
12.
13.

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.

Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65.

PMID:
10094216
14.
16.

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.

Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.

Ann Allergy Asthma Immunol. 2004 Oct;93(4):351-9.

PMID:
15521371
17.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
18.

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.

Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K.

Ann Allergy Asthma Immunol. 1999 Apr;82(4):383-9.

PMID:
10227337
19.

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.

PMID:
15219176
20.

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers.

Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN.

J Allergy Clin Immunol. 2003 Jul;112(1):29-36.

PMID:
12847476
Items per page

Supplemental Content

Support Center